VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
16 hedge funds and large institutions have $1.46M invested in VIVEVE MED INC in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
7% more funds holding
Funds holding: 15 → 16 (+1)
0.01% more ownership
Funds ownership: 6.04% → 6.05% (+0.01%)
13% less capital inflows, than outflows
Capital inflows: $235K | Capital outflows: $270K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$69.4K |
| 2 |
Morgan Stanley
New York
|
+$61.5K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$41.9K |
| 4 |
VF
Virtu Financial
New York
|
+$26.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$192K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$53K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$16.4K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$2.13K |
VIVE Hedge Fund Activity: Q3 2021 in Review
16 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2021, worth a combined $1.46M — down 23% from $1.89M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VIVE positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $69.4K. The largest seller was Goldman Sachs, exiting entirely with an estimated $192K sold.
- 16 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2021, up from 15 in Q2 2021.
- Funds reported $1.46M of VIVEVE MED INC stock for Q3 2021, down 23% quarter-over-quarter.
- 4 funds opened new VIVEVE MED INC positions in Q3 2021 and 3 closed out, a net change of +1 holder.
- The largest VIVEVE MED INC buyer in Q3 2021 was Susquehanna International Group, an estimated $69.4K added.
- The largest VIVEVE MED INC seller in Q3 2021 was Goldman Sachs, an estimated $192K sold.
Based on aggregated 13F filings for Q3 2021.